Chelation Therapy

Heavy-metal toxicity has now been directly associated with cardiovascular disease as well as atherosclerotic coronary artery disease. We are exposed to these toxins almost continually in our food supply. Those born before the advent of unleaded gasoline were exposed to lead daily. Although most lab reports will show a reference range for “Normal” levels, there is no safe level of lead in humans. We are continually exposed to aluminum, mercury and, increasingly, thallium. These are only a few of our ongoing exposures.

The TACT trial (Trial to Assess Chelation Therapy) showed that chelation therapy decreased the occurrence of a second heart attack, in diabetics with a previous heart attack, by greater than 40%.